PIK3CA and neoplasm: PI3K inhibition can cause a reduction in the number of regulating T (T reg) cells, intra-tumoral infiltration of CD4+ and CD8+ T cells, and the production of immunostimulatory cytokines in the tumor microenvironment, thus stimulating anticancer immunity [166].